THE Georgetown Public Hospital Corporation (GPHC) has been promoting vision care through early screenings and tests at its eye clinic and the Vision Centre.

An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight ...

MUSCAT: The National Programme for Early Detection of Diabetic Retinopathy using artificial intelligence (AI) technologies ...

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye ...

Diabetic retinopathy may not cause any symptoms in its early stages, but as the disease progresses, you may experience changes to your vision, including: Blurred vision Vision that fluctuates ...

Analysis - Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage diabetes and obesity around the world.

Fully autonomous screening for diabetic retinopathy is coming to pharmacies and other locations through a strategic ...